Activity ID
14103Expires
September 13, 2025Format Type
LiveCME Credit
1Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
While there is an expanding toolbox of effective treatments for mood disorders, no treatment is without risks. This session covers rare, life-threatening reactions during treatment, focusing on neuroleptic malignant syndrome and serotonin syndrome. Best practices include careful monitoring informed by knowledge of adverse signs to facilitate rapid diagnosis and treatment.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
• Assess the mechanisms and risk factors underlying neuroleptic malignant syndrome, serotonin syndrome, and other serious reactions to treatments used in mood disorders
• Recognize the clinical signs and symptoms of these reactions
• Develop strategies for emergent treatment and ongoing risk management"
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military
